JAFKX Performance — Health Sciences Trust, Series II
Data updated: 2026-08-27
JAFKX returned +7.20% year to date and +31.91% over one year to Jun 2026. Annualised returns are +9.97% over 3 years and +3.72% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $133, against $138 for the category, and to $132 over one year, against $137. Volatility over the past three years was 15.82% a year. In the 12 months to Jun 2026 the fund took in a net $5.7M, and assets reached $251.29M.
JAFKX Growth of $100
What $100 invested in Health Sciences Trust grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | JAFKX | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $132 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $133 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $120 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $182 | $182 |
JAFKX Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +7.20% |
| 1 year | +31.91% |
| 3 years (annualised) | +9.97% |
| 5 years (annualised) | +3.72% |
JAFKX Annual Returns
Calendar-year total returns of Health Sciences Trust, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +7.20% |
| 2025 | +19.20% |
| 2024 | +1.61% |
| 2023 | +4.00% |
| 2022 | −13.22% |
| 2021 | +10.98% |
| 2020 | +26.88% |
| 2019 (Jul–Dec) | +10.00% |
JAFKX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.1% | +0.9% | −6.0% | +1.6% | +3.5% | +8.7% | — | — | — | — | — | — |
| 2025 | +6.1% | −2.1% | −4.4% | +0.1% | −6.3% | +4.1% | −1.0% | +4.2% | +2.6% | +8.4% | +9.5% | −2.1% |
| 2024 | +2.1% | +4.3% | +1.6% | −5.6% | +2.3% | +3.0% | +3.0% | +5.0% | −2.0% | −4.8% | +1.4% | −7.8% |
| 2023 | +0.9% | −4.9% | +1.9% | +3.6% | −2.7% | +3.0% | +0.1% | −1.8% | −4.2% | −4.3% | +6.1% | +7.1% |
| 2022 | −12.9% | −0.6% | +4.9% | −9.2% | −1.3% | −0.4% | +6.0% | −3.3% | −4.4% | +8.0% | +4.3% | −2.9% |
| 2021 | +2.0% | −1.9% | −1.4% | +5.0% | −1.3% | +5.9% | +1.8% | +4.2% | −5.0% | +3.8% | −5.1% | +3.0% |
| 2020 | −2.7% | −4.6% | −7.0% | +14.2% | +7.6% | +0.6% | +3.2% | +1.7% | +1.2% | −1.4% | +9.2% | +4.0% |
| 2019 | — | — | — | — | — | — | −1.3% | −2.9% | −3.7% | +6.6% | +8.6% | +2.9% |
JAFKX Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 15.82%
- 3-year Sharpe ratio: 0.35 (vs 4.5% risk-free rate)
- Best month: +9.46% (Nov 2025)
- Worst month: −7.75% (Dec 2024)
JAFKX Fund Flows
Monthly money in and out of Health Sciences Trust, from SEC Form N-PORT.
- 12-month net flow: $5.7M
- 12-month gross sales (incl. reinvestments): $41.3M
- Sales ÷ redemptions: 1.16×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $500K | $979K | −$480K |
| May 2026 | $198K | $2.8M | −$2.6M |
| Apr 2026 | $361K | $5.1M | −$4.7M |
| Mar 2026 | $233K | $3.1M | −$2.9M |
| Feb 2026 | $627K | $1.6M | −$960K |
| Jan 2026 | $3.1M | $2.9M | $123K |
| Dec 2025 | $373K | $3.1M | −$2.8M |
| Nov 2025 | $1.5M | $4.0M | −$2.5M |
| Oct 2025 | $32.8M | $2.3M | $30.4M |
| Sep 2025 | $696K | $3.0M | −$2.3M |
| Aug 2025 | $755K | $1.1M | −$353K |
| Jul 2025 | $274K | $5.6M | −$5.4M |
JAFKX Assets Under Management
Net assets of Health Sciences Trust by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $251.29M |
| 2026-03-31 | $227.23M |
| 2025-12-31 | $246.20M |
| 2025-09-30 | $216.89M |
| 2025-06-30 | $212.68M |
| 2025-03-31 | $228.30M |
| 2024-12-31 | $235.81M |
| 2024-09-30 | $268.90M |
| 2024-06-30 | $261.70M |
| 2024-03-31 | $276.37M |
| 2023-12-31 | $263.19M |
| 2023-09-30 | $247.69M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.